Infinity Pharmaceuticals Inc. (NASDAQ:INFI) changes shares on Wednesday trading session, with a change of -2.42% or -$0.02 shares. The trading starts at $0.8806 and closed at $0.89 throughout the day. The trading session low price was $0.8704 and day high was $0.90 on Wednesday, June 24. After the session, the Healthcare sector daily volume shifted to 93166.0 while its average volume is 176.77K. In other hand, the INFI market cap reached to $50.39M. While, its current target price is $0.87 according to WSJ.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -5.63% and down -9.24% for month. Its quarterly performance was -10.76% below, while its half year performance is down -19.41%. INFI yearly performance stood at negative -48.34% and fall -9.33% for year-to-date. Current recommendation for Infinity Pharmaceuticals Inc. is 2.50.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. INFI EPS (TTM) for 12-month is -0.77. EPS for this year is -306.60%, while for the next year its value is -0.76. Its EPS Q/Q reached 21.40%. It has an EPS of -18.20% down for past five years.
Let’s take a look on the analyst recommendations on INFI for the current month and previous month. For the current month, 3 of 5 analysts recommend stock as Buy while 1 as Sell, 0 as overweight, 0 as underweight and 1 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $1.00-$3.50. Average target price for INFI was reached at $2.50.
BVF Inc., Vanguard Group, Inc. (The) and Renaissance Technologies, LLC are the top three holders in Infinity Pharmaceuticals Inc. (INFI) stock. On Mar 30, 2020, BVF Inc. has 17.43 million shares which valued 14.6 million. On Mar 30, 2020, Vanguard Group, Inc. (The) owned 2.31 million shares which valued at 1.94 million. On Mar 30, 2020, Renaissance Technologies, LLC has a total of 1.39 million shares which valued at 1.16 million. In the end, Renaissance Technologies, LLC have 2.41% shares outstanding of Infinity Pharmaceuticals Inc. (INFI) on Mar 30, 2020. The insider ownership moved to 3.00% and institutional holding shifted to 50.00%.
The company posted an EPS (TTM) of -0.77. According to the most recent quarter report on (Jun 2020), 5 analysts estimated an average EPS of -0.19, while -0.18 EPS posted a year ago period. Analyst Estimated EPS for INFI published in the report was -0.21–0.16 during the same period. Comparing with last year, the average estimated EPS was -0.18 which is higher than -0.19 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for INFI fall -19.54% for period of 200 days. SMA for 50 days was -10.36% which is showing red signal, while SMA-20 was -4.71%. The moving average value for Infinity Pharmaceuticals Inc. (INFI) is 1.0681 and 0.9529 for 200 and 50 days respectively.